MARATTO

article · Discover Applied Sciences

Artificial intelligence in personalized medicine: transforming diagnosis and treatment

202518 citationsOpen accessKampala International University

Abstract

The concept of personalised medicine, which adapts care to each patient based on their specific characteristics, has been a long-sought dream in the health field. Artificial intelligence (AI) has made this dream a reality with the advent of technology, promising to enhance diagnosis and cure. AI algorithms, such as machine learning and deep learning, can find patterns and correlations in patient data, such as image recognition for cancer, heart diseases, and neurological disorders. AI can also help in the treatment of diseases by evaluating the patient's response to a particular therapy and selecting the optimal treatment regimen based on the patient's genetic and clinical profile. AI can also help in drug discovery and development, predicting the efficacy and safety of new drugs, identifying targets, and designing clinical trials. However, ethical concerns such as data privacy and the need for stable data management systems are still present. The adoption of AI in the healthcare industry is costly, requiring investment in facilities and personnel, and educating healthcare providers on its use. Collaboration between technologists, physicians, scholars, and regulators is crucial to advance the use of AI in the delivery of personalized medicine, ultimately resulting in better lives for patients worldwide.

Research topics

  • Artificial Intelligence in Healthcare and Education
  • Machine Learning in Healthcare
  • Artificial Intelligence in Healthcare

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1007/s42452-025-06625-x

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.